1. Oral Nicotinamide Reduces Actinic Keratoses in Phase II Double-Blinded Randomized Controlled Trials 
Devita Surjana, Gary M. Halliday, Andrew J. Martin, Fergal J. Moloney, Diona L. Damian 
Journal of Investigative Dermatology 
Volume 132, Issue 5, Pages (May 2012)
DOI: /jid
Copyright © 2012 The Society for Investigative Dermatology, Inc Terms and Conditions

2. Figure 1
CONSORT 2010 flow diagram, study 1: nicotinamide 500mg b.d. versus placebo. SCC, squamous cell carcinoma.
Journal of Investigative Dermatology  , DOI: ( /jid )
Copyright © 2012 The Society for Investigative Dermatology, Inc Terms and Conditions

3. Figure 2
CONSORT 2010 flow diagram, study 2: nicotinamide 500mg daily versus placebo.
Journal of Investigative Dermatology  , DOI: ( /jid )
Copyright © 2012 The Society for Investigative Dermatology, Inc Terms and Conditions